May we target double-membrane vesicles and oxysterol-binding protein to combat SARS-CoV-2 infection?
-
Authors
-
-
Shahmohamadnejad, Shiva1
-
Nabavi, Seyed Fazel2, 3
-
Habtemariam, Solomon4
-
Sarkar, Kasturi5
-
Sil, Parames C6
-
Dowran, Razieh7
-
Nabavi, Seyed Mohammad2, 3
-
1
Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
,
(Iran)
-
2
Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
,
(Iran)
-
3
Division of Translational Medicine, Baqiyatallah Hospital, Baqiyatallah University of Medical Sciences, Tehran, Iran.
,
(Iran)
-
4
Pharmacognosy Research Laboratories & Herbal Analysis Services UK, University of Greenwich, Chatham-Maritime, Kent, UK.
-
5
Department of Microbiology, St. Xavier's College, Kolkata, India.
,
(India)
-
6
Department of Molecular Medicine, Bose Institute, Kolkata, India.
,
(India)
-
7
Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
,
(Iran)
- Type
- Published Article
- Journal
-
Cell Biology International
- Publisher
-
Wiley (John Wiley & Sons)
- Publication Date
-
Sep 01, 2020
- Volume
-
44
- Issue
-
9
- Pages
-
1770–1772
- Identifiers
-
DOI: 10.1002/cbin.11400
-
PMID: 32449802
- Source
-
Medline
- Keywords
-
- Language
-
English
- License
-
Unknown
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/04/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at
https://www.ncbi.nlm.nih.gov/pubmed/32449802
